ECSP088723A - New enantiomerically pure beta-agonists, procedures for their preparation and use as medicines - Google Patents

New enantiomerically pure beta-agonists, procedures for their preparation and use as medicines

Info

Publication number
ECSP088723A
ECSP088723A EC2008008723A ECSP088723A ECSP088723A EC SP088723 A ECSP088723 A EC SP088723A EC 2008008723 A EC2008008723 A EC 2008008723A EC SP088723 A ECSP088723 A EC SP088723A EC SP088723 A ECSP088723 A EC SP088723A
Authority
EC
Ecuador
Prior art keywords
medicines
preparation
enantiomerically pure
agonists
procedures
Prior art date
Application number
EC2008008723A
Other languages
Spanish (es)
Inventor
Peter Sieger
Uwe Ries
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ECSP088723A publication Critical patent/ECSP088723A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/5381,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos enantioméricamente puros de la fórmula 1 1en donde los radicales n, B, X, R1, m e Ym- pueden tener los significados mencionados en las reivindicaciones y en la descripción, a procedimientos para su preparación, así como a su preparación como medicamentos, en especial como medicamentos para el tratamiento de enfermedades de las vías respiratorias.The present invention relates to enantiomerically pure compounds of the formula 1 in which the radicals n, B, X, R1, I and Ym- can have the meanings mentioned in the claims and in the description, to processes for their preparation, as well as to its preparation as medicines, especially as medicines for the treatment of diseases of the respiratory tract.

EC2008008723A 2006-03-15 2008-09-08 New enantiomerically pure beta-agonists, procedures for their preparation and use as medicines ECSP088723A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06111191 2006-03-15
EP06111342 2006-03-17
EP06111338 2006-03-17

Publications (1)

Publication Number Publication Date
ECSP088723A true ECSP088723A (en) 2008-10-31

Family

ID=38006901

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008723A ECSP088723A (en) 2006-03-15 2008-09-08 New enantiomerically pure beta-agonists, procedures for their preparation and use as medicines

Country Status (16)

Country Link
US (2) US7534789B2 (en)
EP (1) EP1996581A1 (en)
JP (1) JP2009530245A (en)
KR (1) KR20080106973A (en)
AR (1) AR059836A1 (en)
AU (1) AU2007224420A1 (en)
BR (1) BRPI0709601A2 (en)
CA (1) CA2643026A1 (en)
EA (1) EA200801894A1 (en)
EC (1) ECSP088723A (en)
MX (1) MX2008011700A (en)
NO (1) NO20083508L (en)
PE (1) PE20080142A1 (en)
TW (1) TW200804360A (en)
UY (1) UY30207A1 (en)
WO (1) WO2007104772A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
PE20080142A1 (en) * 2006-03-15 2008-04-14 Boehringer Ingelheim Int ENANTHOMERICALLY PURE BETA-AGONISTS AND THEIR PREPARATION PROCEDURES
SG11201603383VA (en) 2013-10-31 2016-05-30 Allergan Inc Prostamide-containing intraocular implants and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (en) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim AMINOALKYLHETEROCYCLES
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10253282A1 (en) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treatment of chronic obstructive pulmonary disease, using new or known N-substituted 2-amino-1-(benz-(1,4)-oxazin-3-on-8-yl)-ethanol derivative beta-mimetic agents, suitable for once-daily administration
DE102004003428A1 (en) 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting beta-2 agonists, and their use as pharmaceuticals
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024454A1 (en) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel enantiomerically pure beta agonists, process for their preparation and their use as pharmaceuticals
DE102004045648A1 (en) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg New betamimetics for the treatment of respiratory diseases
US20080176744A1 (en) 2005-03-10 2008-07-24 Basf Aktiengesellschaft Use of 4-Aminopyrimidines for Controlling Harmful Fungi, Novel 4-Aminopyrimidines, Processes for Their Preparation and Compositions Comprising Them
CA2642239A1 (en) * 2006-02-16 2007-08-23 Boehringer Ingelheim International Gmbh Drug combinations for the treatment of respiratory tract diseases
PE20080142A1 (en) * 2006-03-15 2008-04-14 Boehringer Ingelheim Int ENANTHOMERICALLY PURE BETA-AGONISTS AND THEIR PREPARATION PROCEDURES

Also Published As

Publication number Publication date
CA2643026A1 (en) 2007-09-20
WO2007104772A1 (en) 2007-09-20
WO2007104772A9 (en) 2007-11-22
MX2008011700A (en) 2008-09-24
NO20083508L (en) 2008-09-30
EA200801894A1 (en) 2009-02-27
EP1996581A1 (en) 2008-12-03
PE20080142A1 (en) 2008-04-14
TW200804360A (en) 2008-01-16
JP2009530245A (en) 2009-08-27
AR059836A1 (en) 2008-04-30
UY30207A1 (en) 2007-10-31
US7534789B2 (en) 2009-05-19
AU2007224420A1 (en) 2007-09-20
US20070249595A1 (en) 2007-10-25
BRPI0709601A2 (en) 2011-07-19
US20090306068A1 (en) 2009-12-10
KR20080106973A (en) 2008-12-09
US7939658B2 (en) 2011-05-10

Similar Documents

Publication Publication Date Title
ECSP077331A (en) NEW BETAMIMETICS FOR THE TREATMENT OF RESPIRATORY ROAD DISEASES
HN2009000784A (en) SUBSTITUTED DIHYDROPIRAZOLONES
CR20120264A (en) COMPOUNDS
CO6491058A2 (en) DERIVATIVES OF OXAZINE AND ITS USE AS BACE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
GT201300243A (en) RAMIFIED 3-PHENYLPROPIONIC ACID DERIVATIVES AND ITS USE
UY28473A1 (en) NEW COMPOUNDS
GT200900230A (en) 4-ARIL-1,4-DIHIDRO-1,6-NAFTIRIDINAMIDES REPLACED AND USE
UY31228A1 (en) ARILOXAZOLES REPLACED AND ITS USE
CR20130339A (en) NEW HETEROCYCLIC DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
PE20050255A1 (en) NEW CYANTIAZOLIDES AND PROCEDURE FOR THEIR PREPARATION AS MEDICINES
CU24037B1 (en) DICIANOPIRIDINS ALQUILAMINO-REPLACED AND ITS AMINO ACID ESTER PROPHARMACES
UY31310A1 (en) 6-PHENYLNICOTINIC ACIDS REPLACED AND ITS USE
ECSP066734A (en) ACID DERIVATIVES 7-PHENYLAMINE-4-QUINOLONA-3-CARBOXYL, METHODS FOR PRODUCTION AND USE AS MEDICATIONS
UY29079A1 (en) PHENOXYACETIC ACIDS REPLACED, COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
ECSP066948A (en) BENZOXAZINES FOR THE TREATMENT OF RESPIRATORY ROAD DISEASES
UY28861A1 (en) NEW PHARMACOLOGICAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY ROAD DISEASES
UY32744A (en) DERIVATIVES OF 2-CARBOXAMIDA-7-PIPERAZINIL-BENZOFURANO 774
CU20090216A7 (en) (OXAZOLIDINON-5-IL-METIL) -2-REPLACED THIOPHEN-CARBOXAMIDS AND ITS USE IN THE FIELD OF THE BLOOD COAGULATION
ECSP066770A (en) NEW CUATERNIZED QUINUCLIDINE ESTERS
AR057148A1 (en) PHARMACOLOGICAL COMBINATIONS FOR THE TREATMENT OF RESPIRATORY ROAD DISEASES
ECSP099082A (en) BETA-ENANTIOMERICALLY PURE AGONISTS, PROCEDURES FOR THEIR PREPARATION AND USE AS MEDICATIONS
UY28896A1 (en) POWDER FORMULATIONS FOR INHALATION, WHICH CONTAIN BETA-ENANTIOMERALLY PURE AGONISTS
GT200600109A (en) PYRIMIDINCARBOXILIC ACID DERIVATIVES AND ITS USE
AR062475A1 (en) PHARMACOLOGICAL COMBINATIONS FOR THE TREATMENT OF AIRWAY DISEASES
CO6382113A2 (en) CHEMICAL COMPOUNDS